Whole exome sequencing of 8 CLL patients with dysfunctional TP53 and a median time of 15.4 months from initial treatment until progression uncovered heterogeneous clonal evolution under venetoclax treatment. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.